A Managed Care Review of Schizophrenia: Evaluating Unmet Medical Needs, New Treatments, and Health Economics

pharmacytimes.org/on-demand/a-managed-care-review-of-unmet-medical-needs-new-treatments-and-health-economics-associated-with-schizophrenia-supplement

Related Videos

Related Content

Advertisement

November 26th 2024

New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Kyle Munz

If made official, the proposed rule would give Part D and Medicaid beneficiaries expanded coverage to antiobesity drugs starting in 2026.

November 21st 2024

Frameworks for Advancing Health Equity: Wellness Way

Giuliana Grossi

The Wellness Way facility was designed to improve access to comprehensive outpatient care and address social determinants of health for a diverse patient population.

November 26th 2024

FDA Approves Imatinib Oral Solution for Treatment of Various Cancers

Kyle Munz

The FDA approval marks the first oral solution indicated for patients with different forms of leukemia.

October 29th 2024

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa

Giuliana Grossi

Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.

November 26th 2024

Metformin Improves Symptoms and Gene Expression in Central Centrifugal Cicatricial Alopecia

Cameron Santoro

Patients with treatment-resistant central centrifugal cicatricial alopecia saw improvement in symptoms and gene expression, suggesting the potential of metformin as a new treatment option.

November 26th 2024

Key Flu and RSV Recommendations for the 2024-2025 Respiratory Virus Season

Lauren Biscaldi, MS

A presentation at the National Community Pharmacists Association Annual Meeting and Exposition focused on the latest on vaccines for flu and respiratory syncytial virus (RSV).

Related Content

Advertisement

November 26th 2024

New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Kyle Munz

If made official, the proposed rule would give Part D and Medicaid beneficiaries expanded coverage to antiobesity drugs starting in 2026.

November 21st 2024

Frameworks for Advancing Health Equity: Wellness Way

Giuliana Grossi

The Wellness Way facility was designed to improve access to comprehensive outpatient care and address social determinants of health for a diverse patient population.

November 26th 2024

FDA Approves Imatinib Oral Solution for Treatment of Various Cancers

Kyle Munz

The FDA approval marks the first oral solution indicated for patients with different forms of leukemia.

October 29th 2024

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa

Giuliana Grossi

Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.

November 26th 2024

Metformin Improves Symptoms and Gene Expression in Central Centrifugal Cicatricial Alopecia

Cameron Santoro

Patients with treatment-resistant central centrifugal cicatricial alopecia saw improvement in symptoms and gene expression, suggesting the potential of metformin as a new treatment option.

November 26th 2024

Key Flu and RSV Recommendations for the 2024-2025 Respiratory Virus Season

Lauren Biscaldi, MS

A presentation at the National Community Pharmacists Association Annual Meeting and Exposition focused on the latest on vaccines for flu and respiratory syncytial virus (RSV).